Insights on Health Care

Health Care Partner Stephanie Trunk will participate in the External Counsel Fireside Chat at Informa Connect’s Pricing & Contracting USA 2025 conference in Philadelphia, Pennsylvania, on May 21.

There are currently six states with active Prescription Drug Affordability Boards (PDABs) — Colorado, Maryland, Washington, Oregon, New Hampshire, and Minnesota.

Headlines that Matter for Companies and Executives in Regulated Industries

A litigation before a court in one jurisdiction may require taking third-party discovery from third parties located in different jurisdictions. Litigants seeking third-party discovery from parties in other states may quickly discover that the process can be more complex than expected.

The ArentFox Schiff Life Sciences team takes a look at what changes may impact life sciences companies in 2025.

Headlines that Matter for Companies and Executives in Regulated Industries

Anthem Inc. has agreed to settle a class action lawsuit brought by participants in employee health plans administered by the insurer.

Ambulatory surgery centers (ASCs) have become a large and growing part of the health care industry. ASCs offer same-day surgical care, including diagnostic and preventive procedures, and their popularity has recently grown.

Headlines that Matter for Companies and Executives in Regulated Industries

President Trump’s Executive Order (EO) 14187, “Protecting Children from Chemical and Surgical Mutilation,” represents a significant shift in federal policy regarding gender-affirming care (GAC) for minors.

Gayland Hethcoat was quoted on the potential for increased data privacy litigation targeting health plans, with the Blue Shield case possibly sparking a “broader wave” of lawsuits.

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of the Inspector General (OIG), manufacturers have contested the OIG’s long-standing interpretation of the Anti-Kickback Statute (AKS).

Headlines that Matter for Companies and Executives in Regulated Industries

On March 31, a judge in the Eastern District of Texas vacated the US Food and Drug Administration’s (FDA) rule that sought to regulate laboratory-developed tests (LDTs) as medical devices under the Federal Food, Drug, and Cosmetic Act (FDCA).

Partner David Greenberg was quoted on a series of patient lawsuits challenging the alleged use of artificial intelligence (AI) and algorithms by health insurers, commenting on the potential hazards of insurers using the technology.

Health Care Partner Debra Albin-Riley will participate in a session titled “Emerging Medical Staff Trends” at the California Society for Healthcare Attorneys’ (CSHA) 2025 Annual Meeting & Spring Seminar on April 6, 2025.

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Partner Hillary Stemple was recently quoted on how physicians and other providers can navigate visits from drug and device manufacturer representatives, highlighting the legal and ethical complexities involved.

Health Care Practice Leader Douglas A. Grimm was quoted by Relias Media, urging hospitals and health care providers to prepare for potential Immigration and Customs Enforcement raids at their locations, following the Trump administration’s revocation of policies that previously made hospitals off-limits for immigration enforcement.

This past year, in the wake of significant economic challenges facing the health care industry, an unprecedented number of receiverships were imposed upon skilled nursing facilities in Massachusetts. Historically, Massachusetts receiverships have been used sparingly as a tool to address distressed or insolvent situations, with bankruptcy being the favored option.

The US District Court for the Eastern District of New York in Manalapan Surgery Ctr., et al. v. 1199 SEIU National Benefit Fund, No. 23-CV-03525 (EDNY March 12, 2025), recently granted a motion to dismiss a complaint filed by four out-of-network ambulatory surgery centers against 1199 SEIU National Benefit Fund.

Headlines that Matter for Companies and Executives in Regulated Industries

On March 27, the US Department of Health and Human Services (HHS) announced a significant restructuring initiative in accordance with President Trump’s Executive Order, “Implementing the President’s Department of Government Efficiency Workforce Optimization Initiative.”

In the last year, state activism in healthcare consumer protection has surged, with new laws that heighten oversight of for-profit investors’ engagement with healthcare marketplaces and scrutinize pharmaceutical pricing practices. As part of this activism, several state legislatures have enacted laws regulating use of artificial intelligence (AI) in healthcare delivery.

Headlines that Matter for Companies and Executives in Regulated Industries